Cargando…
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
Autores principales: | Gallay, Laure, Uzunhan, Yurdagül, Borie, Raphael, Lazor, Romain, Rigaud, Pierre, Marchand-Adam, Sylvain, Hirschi, Sandrine, Israel-Biet, Dominique, Valentin, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874431/ https://www.ncbi.nlm.nih.gov/pubmed/33252997 http://dx.doi.org/10.1164/rccm.202007-2638LE |
Ejemplares similares
-
Whatever ‘smells’ like COVID-19 is not always COVID-19
por: Vasarmidi, Eirini, et al.
Publicado: (2022) -
Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
por: Hervier, Baptiste, et al.
Publicado: (2020) -
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
por: Sesé, Lucile, et al.
Publicado: (2021) -
Blood ferritin and isoferritins measurements may be helpful in acute respiratory distress syndrome patients
por: Uzunhan, Yurdagul, et al.
Publicado: (2002) -
MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)